Light Sciences Spin-Offs Focus On Photodynamic Therapy R&D
This article was originally published in The Gray Sheet
Executive Summary
Light Sciences Oncology is conducting Phase II clinical trials for a next generation photodynamic therapy (PDT) to treat liver metastases arising from colorectal cancer
You may also be interested in...
Photodynamic Therapy Gets Good Marks For Attacking Certain Skin Cancers
Photodynamic therapy is effective in treating some types of non-melanoma skin tumors, according to an Interventional Procedures Advisory Committee (IPAC) draft recommendation published Oct. 25 by Britain's National Institute for Health & Clinical Excellence (see chart: "1NICE Interventional Procedure Consultations For September, November")
Photodynamic Therapy Gets Good Marks For Attacking Certain Skin Cancers
Photodynamic therapy is effective in treating some types of non-melanoma skin tumors, according to an Interventional Procedures Advisory Committee (IPAC) draft recommendation published Oct. 25 by Britain's National Institute for Health & Clinical Excellence (see chart: "1NICE Interventional Procedure Consultations For September, November")
Off-Label Photodynamic Therapy Coverage Extended To AMD Population
Clinical trial subgroup analyses showing the ability of lesion size to predict patient benefit helped convince CMS to expand national Medicare coverage of QLT/Novartis' Visudyne (verteporfin)